JP2019534709A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019534709A5 JP2019534709A5 JP2019537752A JP2019537752A JP2019534709A5 JP 2019534709 A5 JP2019534709 A5 JP 2019534709A5 JP 2019537752 A JP2019537752 A JP 2019537752A JP 2019537752 A JP2019537752 A JP 2019537752A JP 2019534709 A5 JP2019534709 A5 JP 2019534709A5
- Authority
- JP
- Japan
- Prior art keywords
- isolated polynucleotide
- polynucleotide molecule
- rsv
- protein
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022144109A JP7573001B2 (ja) | 2016-09-23 | 2022-09-09 | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
| JP2024178707A JP2025020142A (ja) | 2016-09-23 | 2024-10-11 | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662399133P | 2016-09-23 | 2016-09-23 | |
| US62/399,133 | 2016-09-23 | ||
| US201662400476P | 2016-09-27 | 2016-09-27 | |
| US62/400,476 | 2016-09-27 | ||
| PCT/US2017/053047 WO2018057950A1 (en) | 2016-09-23 | 2017-09-22 | Vaccine candidates for human respiratory syncytial virus (rsv) having attenuated phenotypes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022144109A Division JP7573001B2 (ja) | 2016-09-23 | 2022-09-09 | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019534709A JP2019534709A (ja) | 2019-12-05 |
| JP2019534709A5 true JP2019534709A5 (enExample) | 2020-10-08 |
| JP7198759B2 JP7198759B2 (ja) | 2023-01-04 |
Family
ID=60009756
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019537752A Active JP7198759B2 (ja) | 2016-09-23 | 2017-09-22 | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
| JP2022144109A Active JP7573001B2 (ja) | 2016-09-23 | 2022-09-09 | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
| JP2024178707A Pending JP2025020142A (ja) | 2016-09-23 | 2024-10-11 | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022144109A Active JP7573001B2 (ja) | 2016-09-23 | 2022-09-09 | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
| JP2024178707A Pending JP2025020142A (ja) | 2016-09-23 | 2024-10-11 | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
Country Status (5)
| Country | Link |
|---|---|
| US (4) | US10808012B2 (enExample) |
| EP (1) | EP3515930A1 (enExample) |
| JP (3) | JP7198759B2 (enExample) |
| AU (4) | AU2017332789B2 (enExample) |
| WO (1) | WO2018057950A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4190895A1 (en) | 2013-02-08 | 2023-06-07 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization |
| US10808012B2 (en) | 2016-09-23 | 2020-10-20 | The Usa, As Represented By The Secretary, Dept. Of Health And Human Services | Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes |
| RU2020124143A (ru) | 2017-12-22 | 2022-01-24 | Кодадженикс Инк. | Рекомбинантный вирус с областью деоптимизированной пары кодонов и его применение для лечения рака |
| CA3091508A1 (en) | 2018-03-08 | 2019-09-12 | Codagenix Inc. | Attenuated flaviviruses |
| AU2021271702A1 (en) | 2020-05-13 | 2023-01-19 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | RSV vaccine bearing one or more P gene mutations |
| EP4181956A4 (en) * | 2020-07-16 | 2024-08-07 | Griffith University | VACCINE AGAINST A LIVE ATTENUATED VIRUS |
| CN117693360A (zh) * | 2021-04-08 | 2024-03-12 | 科达金尼克斯有限公司 | 引发针对呼吸道合胞病毒的免疫应答的方法 |
| WO2025054424A1 (en) * | 2023-09-06 | 2025-03-13 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Human parainfluenza virus immunogenic molecules |
| WO2025128971A1 (en) * | 2023-12-14 | 2025-06-19 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Rsv vaccine bearing a polynucleotide which is de-optimised and de-attenuated |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3224404A1 (de) | 1982-06-30 | 1984-01-05 | LuK Lamellen und Kupplungsbau GmbH, 7580 Bühl | Reibungskupplung sowie verfahren zu deren montage |
| WO1997012032A1 (en) | 1995-09-27 | 1997-04-03 | The Government Of The United States Of America, As Represented By The Department Of Health And Human Services | Production of infectious respiratory syncytial virus from cloned nucleotide sequences |
| EP0912724B1 (en) | 1996-07-15 | 2009-12-09 | The Government of The United States of America, as represented by The Department of Health and Human Services | Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| DE69842165D1 (de) | 1997-05-23 | 2011-04-21 | Us Of America As Represented By The Secretary Of The Dept Of Health And Human Services | Herstellung attenuierter parainfluenza-virus impfstoffe aus klonierten nukleotidsequenzen |
| AU4065500A (en) | 1999-04-13 | 2000-11-14 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| WO2002042326A1 (en) | 2000-11-22 | 2002-05-30 | Biota Scientific Management Pty Ltd | A method of expression and agents identified thereby |
| WO2006085987A2 (en) | 2004-07-09 | 2006-08-17 | University Of Iowa Research Foundation | Rna interference in respiratory epitheial cells |
| CA2587084C (en) | 2004-10-08 | 2019-07-16 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Modulation of replicative fitness by using less frequently used synonym ous codons |
| KR101621100B1 (ko) | 2007-03-30 | 2016-05-13 | 더 리서치 파운데이션 오브 스테이트 유니버시티 오브 뉴욕 | 백신에 유용한 약독화 바이러스 |
| MX2011004719A (es) | 2008-11-05 | 2011-05-31 | Merck Sharp & Dohme | Virus sincitial respiratorio vivo atenuado. |
| US10227569B2 (en) | 2011-04-12 | 2019-03-12 | Emory University | Respiratory syncytial virus expression vectors |
| EP4190895A1 (en) * | 2013-02-08 | 2023-06-07 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization |
| US10808012B2 (en) | 2016-09-23 | 2020-10-20 | The Usa, As Represented By The Secretary, Dept. Of Health And Human Services | Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes |
-
2017
- 2017-09-22 US US16/335,099 patent/US10808012B2/en active Active
- 2017-09-22 JP JP2019537752A patent/JP7198759B2/ja active Active
- 2017-09-22 EP EP17778443.6A patent/EP3515930A1/en active Pending
- 2017-09-22 AU AU2017332789A patent/AU2017332789B2/en active Active
- 2017-09-22 WO PCT/US2017/053047 patent/WO2018057950A1/en not_active Ceased
-
2020
- 2020-08-31 US US17/008,025 patent/US11390651B2/en active Active
-
2021
- 2021-08-19 AU AU2021218112A patent/AU2021218112B2/en active Active
-
2022
- 2022-06-28 US US17/851,905 patent/US12054519B2/en active Active
- 2022-09-09 JP JP2022144109A patent/JP7573001B2/ja active Active
- 2022-10-21 AU AU2022256195A patent/AU2022256195B2/en active Active
-
2024
- 2024-06-11 AU AU2024203948A patent/AU2024203948A1/en active Pending
- 2024-06-28 US US18/758,660 patent/US20240417431A1/en active Pending
- 2024-10-11 JP JP2024178707A patent/JP2025020142A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019534709A5 (enExample) | ||
| JP2016534034A5 (enExample) | ||
| IL276210B2 (en) | Mers-cov vaccine | |
| MX2020002876A (es) | Metodo para la induccion segura de inmunidad contra el vsr. | |
| JP2016539946A5 (enExample) | ||
| RU2016146801A (ru) | Вакцинная композиция против инфекции, вызванной streptococcus suis | |
| RU2019139064A (ru) | Композиции и способы для лечения цитомегаловируса | |
| JP2018504412A5 (enExample) | ||
| HRP20230694T1 (hr) | Smanjenje ljudskog respiratornog sincicijskog virusa prema ljestvici genoma deoptimizacijom kodon-para | |
| WO2014205579A4 (en) | Modified matrix proteins of vesicular stomatitis virus | |
| JP2016520530A5 (enExample) | ||
| EP2552490A4 (en) | INFLUENZA MATRIX 2 PROTEIN ECKTOMOMAS, EXPRESSION SYSTEM THEREFOR AND USES THEREOF | |
| JP2019500320A5 (enExample) | ||
| JP2019505567A5 (enExample) | ||
| JP2018524019A5 (enExample) | ||
| KR20120032486A (ko) | 면역화 요법용 발현 벡터로서의 수포성 구내염 바이러스의 상이한 혈청형 | |
| FI3511015T9 (fi) | Geneettisesti stabiili elävä heikennetty respiratory syncytial -virusrokote ja sen tuottaminen | |
| CN107344969B (zh) | 一种纳米流感疫苗及构建方法和应用 | |
| JP2015525794A5 (enExample) | ||
| JP2020515283A5 (enExample) | ||
| RU2018112060A (ru) | Слитый белок | |
| JP2012517239A5 (enExample) | ||
| CN103316357B (zh) | 携带rsv基因的重组流感病毒嵌合疫苗及其制备方法 | |
| JP2018536428A5 (enExample) | ||
| JP2020522249A5 (enExample) |